Collegium Pharmaceutical

Vice President, Investor Relations

Job Locations US-MA-Stoughton
Posted Date 1 month ago(8/22/2022 6:28 PM)
# of Openings




At Collegium Pharmaceutical, we are building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We have a portfolio of meaningfully differentiated medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.




Based in Stoughton, MA (hybrid model) and reporting to the Chief Financial Officer, the Vice President, Investor Relations will develop and execute an integrated IR strategy that will align to and promote the business objectives and enhance the image and reputation of the company.  This role will lead investor relations strategies and activities, specifically overseeing analyst and investor engagement. 


The Head of Investor Relations must partner closely with finance, commercial, corporate communications, and the Executive Committee to articulate an accurate and concise message to the investment community as the company embarks on the next phase of its strategy to build a leading, diversified specialty pharmaceutical company. 


This leader will be expected to take a strategic and proactive approach toward the execution of the IR function.  This individual will need to be investor and capital market savvy, and will work closely with the CEO, CFO, and other functions to sharpen and improve the message regarding where the company is now and where it is going.


The Head of Investor Relations will serve as a strategic advisor to the CEO and CFO in preparing for earnings calls, investor meetings, and industry conferences.  This role will prepare senior executives for their interaction with the investment community and act as a conduit for information from the investment community to internal stakeholders.  It is critical, as a key communications leader, that this individual develop an in-depth, comprehensive understanding of the company’s operations, financial performance, and strategies through their interaction with company executives and business leaders.



  • Lead a proactive and strategic investor relations function built on best-practices and knowledge of the investment community as the company scales to a leading, diversified specialty pharmaceutical company.
  • Identify the key metrics used by the buy-side and sell-side to assess performance and results and incorporate those data points into a consistent message.
  • Partner with the CEO and CFO to lead and manage the company’s participation on quarterly earnings calls, investment conferences, road shows, analyst days, and one-to-one meetings.
  • Conduct analysis and research in support of the earnings call process, including the analysis of competitor operating results and industry trends. Specifically, the Sr. Director of Investor Relations will leverage competitive intelligence to craft a concise and differentiating message that sets the company apart from its peer group.
  • Serve as a primary point of contact for all investor inquiries; cultivate and maintain strong relationships with investors (current and potential future), sell-side research analysts, and other key stakeholders. Provide timely, consistent, compliant, and accurate responses.
  • Collaborate with senior leadership to create the company’s external and internal messaging and ensure all external and internal communications are integrated and consistent.
  • Collaborate closely with Corporate Communications to ensure a consistent message on branding and strategy.
  • Along with CEO, CFO, and other members of the senior management team, serve as spokesperson for the company at investment presentations, institutions, individual investor meetings and discussions as needed.
  • Lead external strategic communications development, such as preparing presentation decks, developing earnings press releases, creating management Q&As, and conference call scripts.
  • Present and articulate the investor point of view to the executive team and board of directors and make recommendations as necessary and appropriate.
  • Effectively anticipate investor concerns, questions, and needs by keeping current on the industry and competitive landscape while maintaining a deep understanding of Collegium’s business and progress.
  • Work closely with executive leadership to establish the optimal mix of shareholders through targeting initiatives.
  • Direct and manage external agency that is supporting investor communications and activities.
  • Maintain and communicate competitive intelligence and analysis and its impact on the business to senior management.
  • Lead and manage the Investor Relations portion of the company website.
  • Collaborate with colleagues throughout the company in establishing the strategy development, operating plan, budget, and the detailed execution of the IR operating plan.
  • Partner closely with Finance, Legal, Corporate Communications and other departments to ensure accurate and appropriate information for financial reporting, including as part of quarterly communications and regular SEC filings.




  • Leadership Behaviors are a core set of behaviors that vary based on Level in the organization. We have categorized these under Head, Heart, and Guts.
  • Reference the Career Stage 3 Leadership Behaviors: Leader of Others- Maximize Own Impact materials for specific behaviors under each category.


Candidate Profile


The ideal candidate will be an energetic, roll-up-the-sleeves investor relations leader in the life sciences industry or an established buy-side or sell-side equity analyst covering the life sciences industry.  The Sr. Director of Investor Relations must possess deep financial acumen, the ability to steer business performance, make important decisions and have a down-to-earth business sense.  Additionally, exposure to commercial stage pharmaceutical or biotech companies through previous roles is required.


The successful candidate will have outstanding communication and interpersonal skills; comprehensive business acumen; and the presence and leadership ability to maintain a high level of trust, credibility and confidence with the company’s leadership team.  In addition, it is imperative that the individual must be seen as a strong businessperson who knows how to partner with senior executives and guide change.  Experience in a high-visibility external role where judgement, tact, flexibility and resourcefulness are required.  Beyond functional skills and experiences, this individual must have a keen intellect and unquestioned ethics.


Additional qualifications include:


  • Investor relations or equity research (buy-side or sell-side) experience within or covering pharmaceutical or biotechnology companies.
  • Strong financial acumen; well versed with all of the company’s key financial statements. Must have a clear and thorough understanding of financial modelling used by investment professionals to value the organization’s performance.
  • Deep ability to communicate the strategic and financial message to the investor community through decks, reports and press releases.
  • Strong reputation with Wall Street analysts and institutional investors.
  • An individual with strong emotional intelligence and tenacity for driving change.
  • Ability to manage multiple priorities and work with and influence executives and cross-functional team members.
  • Ability to develop, synthesize and present perspectives on key strategic/financial issues.
  • Proactive, self-motivated, and detail-oriented.
  • 10+ years of experience in investor relations required; minimum of 3 years experience in pharmaceutical or biotech (or covering sector) required.


Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed

Need help finding the right job?

We can recommend jobs specifically for you! Click here to get started.